FSD Pharma Inc C.HUGE

JUST FACTS

[Chuckie18]

Mr. Latowsky is presently the CEO of Canntab Therapeutics Ltd., an innovator for pharmaceutical use in hard-pill form for cannabinoid and terpene mixing. Mr. Latowsky occupied a number formerly president and CEO of Katz's group Canada which is the biggest network of Canadian Pharmaceutical retailers working under the headings of Rexall, Pharmaplus, IDA and Guardian Drugstores during his career, including the President & Chief Executive Officer of Top Drug Corp. from 2014-2020.. He also headed Propharm Technology and DC Labs, a vertical prescription and over-the-counter commodity production and packaging division.

[Chuckie18]

Unless, according to this Circular, the shareholders concerned will vote (or cancel voting) in accordance with your orders on any voting which you will call to that meeting, your stock covered by this proxy will be selected if a proxy form is made available to interested shareholders by the representatives chosen as proxies, in conformity with this Circular.

[Chuckie18]

In the case that an acting proxy with a corresponding date is concluded and signed and returned in a proxy form given to its shareholders or in the final distribution by some other entity before the shareholders have been made available.

[Chuckie18]

The First Republic is a free retailer in Canada. Richard Goldstein is Managing Partner and Managing Director, and Anthony Durkacz is the owner and Managing Director of the controlling company. The First Republic holds 163 254 assurances of Class B shares to help these dealer owners (which, for greater certainty, do not include Mr. Durkacz). On 16 October 2019, First Republic acquired 11,970 class

[Chuckie18]

The Representatives of the Shareholders concerned are currently prepared at the meeting to vote in favour, unless otherwise requested by an actionary depositing a proxy, for the election of the five nominated members of the Board of Directors rather than any nominated candidates. See "Choosing Directors" for more details

[Chuckie18]

Mr. Kaushal has been Director 3 Sixty since June 2019. Sixty. 3 On 9 June 2020, Sixty announced that it had not been able to file its annual financial statements and further management discussions and reviews during the period prescribed for such disclosures for the financial year ended 31 December 2019. 3 On July 18, 2020, the Ontario Securities Commission (OSC) released the MCTO (the "MCTO

[Chuckie18]

Where within one year or in this position the applicant has served as the director or executive officer, he or she is bankrupt, has demanded or been subject to arbitration, an arrangement or a deal with creditors, or has received recipient, receiver or agent of the recipient, or otherwise;

[Chuckie18]

The company was stripped of its status as director or managing director by an order issued after the election of the shareholders concerned as a result of an incident in which the nominating sharehood acting as managing director or management manager

[Chuckie18]

Mr. Durkacz and Mr. Saeed have been staff or senior managers of the company for the last three financial years. Mr. Durkacz was Executive Co-Chairman between October 2018 and 17 November 2020. Mr. Saeed was President of FSD from May 2019 to January 25, 2021; he was Executive Vice-Chairman of FV Pharma Inc. from 1 December 2017 to May 2019. For more info on Mr. Durkacz and Mr. Saeed, see "On

[Chuckie18]

Under the terms of the National Instrument, the FSD is "neutral" to Nitin Kaush, Lawrence Latowsky and Fernando Cugliaria, who is to be made aware of the corporate governance practices and national instrument 52-110. Many of the participants involved have the credentials and are "financially knowledgeable" to members of the FSD audit committee. We expect a majority of the